Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of David Agorku
Introduction
David Agorku is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of biomedical research, particularly in the isolation of human cells from murine hosts. His innovative approach has the potential to enhance research methodologies in cell biology.
Latest Patents
Agorku holds a patent for a process titled "Depletion of mouse cells for isolation of human cells." This patent describes a method for depleting host cells from a xenograft of human cells on a murine host. The process involves fragmenting the xenograft, using antibodies specific for a murine CD9 epitope, and collecting the target cells that are not bound by these antibodies. This innovative technique is crucial for advancing research in human cell isolation.
Career Highlights
David Agorku is currently employed at Miltenyi Biotec GmbH, a company renowned for its contributions to cell and gene therapy. His work at Miltenyi Biotec has allowed him to collaborate with leading experts in the field, further enhancing his research capabilities and impact.
Collaborations
Some of Agorku's notable coworkers include Andreas Bosio and Olaf Hardt. Their collaborative efforts contribute to the innovative environment at Miltenyi Biotec, fostering advancements in biomedical research.
Conclusion
David Agorku's contributions to the field of cell biology through his innovative patent and work at Miltenyi Biotec highlight the importance of research in advancing medical science. His work exemplifies the impact that dedicated inventors can have on the scientific community.